A Selective Culture Medium for Screening Ceftazidime-Avibactam Resistance in Enterobacterales and Pseudomonas aeruginosa

被引：11

作者：

Sadek, Mustafa ^{[1
]}

Poirel, Laurent ^{[1
,2
,3
]}

Tinguely, Camille ^{[1
]}

Nordmann, Patrice ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Fribourg, Fac Sci & Med, Med & Mol Microbiol, Fribourg, Switzerland

[2] Univ Fribourg, INSERM European Unit IAME, Fribourg, Switzerland

[3] Univ Fribourg, Swiss Natl Reference Ctr Emerging Antibiot Resist, Fribourg, Switzerland

[4] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland

[5] Univ Hosp Ctr, Lausanne, Switzerland

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2020年 / 58卷 / 09期

基金：

瑞士国家科学基金会;

关键词：

ceftazidime; avibactam; screening; Enterobacterales; Pseudomonas aeruginosa; INFECTIONS;

D O I：

10.1128/JCM.00965-20

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The SuperCAZ/AVI medium was developed for screening ceftazidime-avibactam (CZA) resistance among Gram-negative bacteria (Enterobacterales and Pseudomonas aeruginosa). It was evaluated using 50 CZA-susceptible and 42 CZA-resistant Gram-negative isolates. Its sensitivity and specificity of detection were 100%. Excellent performance of the medium was also observed by testing spiked stools, with the lower limit of detection ranging from 10(1) to 10(2) CFU/ml. This screening medium provides the opportunity to detect CZA-resistant isolates regardless of their resistance mechanisms.

引用

页数：5

共 50 条

[1] A Selective Culture Medium for Screening Ceftazidime-Avibactam Resistance in Enterobacterales and Pseudomonas aeruginosa (vol 58, e00965-20, 2020)
Sadek, Mustafa
Poirel, Laurent
Tinguely, Camille
Nordmann, Patrice
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (12)
[2] A Selective Medium for Screening Ceftazidime/Avibactam Resistance in Carbapenem-Resistant Enterobacterales
Zeng, Weiliang
Liao, Wenli
Zhao, Yajie
Wang, Lingbo
Shu, Hongyun
Jia, Huaiyu
Chen, Tao
Zhang, Ying
Zhou, Tieli
Wu, Qing
[J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
[3] Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam
Kresken, Michael
Koerber-Irrgang, Barbara
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (09)
[4] KPC variants conferring resistance to ceftazidime-avibactam in Pseudomonas aeruginosa strains
Hu, Yanyan
Shen, Weiyi
Lin, Di
Wu, Yuchen
Zhang, Yanyan
Zhou, Hongwei
Zhang, Rong
[J]. MICROBIOLOGICAL RESEARCH, 2024, 289
[5] A Selective Culture Medium for Screening Cefiderocol Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii
Ibrahim, Ahmad
Bouvier, Maxime
Sadek, Mustafa
Decousser, Jean-Winoc
Poirel, Laurent
Nordmann, Patrice
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (07)
[6] Multicenter Evaluation of Ceftazidime-Avibactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa on the Vitek 2 System
Humphries, Romney
Campeau, Shelley
Davis, Thomas E.
Nagaro, Kristin J.
LaBombardi, Vincent J.
Franklin, Simone
Heimbach, Lisa
Dwivedi, Hari P.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (03)
[7] Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo
Zeyu Huang
Yijia Han
Xiaotuan Zhang
Yao Sun
Yuzhan Lin
Luozhu Feng
Tieli Zhou
Zhongyong Wang
[J]. BMC Microbiology, 23
[8] Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
Daikos, George L.
da Cunha, Clovis Arns
Rossolini, Gian Maria
Stone, Gregory G.
Baillon-Plot, Nathalie
Tawadrous, Margaret
Irani, Paurus
[J]. ANTIBIOTICS-BASEL, 2021, 10 (09):
[9] Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa
Corbella, Laura
Boan, Jorge
San-Juan, Rafael
Fernandez-Ruiz, Mario
Carretero, Octavio
Lora, David
Hernandez-Jimenez, Pilar
Ruiz-Ruigomez, Maria
Rodriguez-Goncer, Isabel
Tiago Silva, Jose
Lopez-Medrano, Francisco
Lizasoain, Manuel
Villa, Jennifer
Manuel Caro-Teller, Jose
Aguado, Jose M.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (02)
[10] Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa
Nichols, Wright W.
Stone, Gregory G.
Newell, Paul
Broadhurst, Helen
Wardman, Angela
MacPherson, Merran
Yates, Katrina
Riccobene, Todd
Critchley, Ian A.
Das, Shampa
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)

← 1 2 3 4 5 →